Extensively Hydrolyzed Formula: Hypoallergenicity
This study has been completed.
Sponsor:
Nestlé
Information provided by (Responsible Party):
Nestlé
ClinicalTrials.gov Identifier:
NCT01278446
First received: January 14, 2011
Last updated: January 16, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The primary objective of this clinical trial is to determine whether a new extensively hydrolyzed infant formula is hypoallergenic.
| Condition | Intervention |
|---|---|
|
Food Hypersensitivity |
Other: Extensively hydrolyzed, whey protein infant formula Other: Extensively hydrolyzed, casein protein infant formula |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Prevention |
| Official Title: | Evaluation of Hypoallergenicity of a 100% Whey, Extensively Hydrolyzed Infant Formula |
Resource links provided by NLM:
Further study details as provided by Nestlé:
Primary Outcome Measures:
- Hypoallergenicity [ Time Frame: 14 Days ] [ Designated as safety issue: Yes ]To demonstrate that the test formula does not provoke allergenic activity
Secondary Outcome Measures:
- Digestive Tolerance [ Time Frame: 1 Week ] [ Designated as safety issue: No ]
| Enrollment: | 82 |
| Study Start Date: | February 2011 |
| Study Completion Date: | August 2012 |
| Primary Completion Date: | June 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Test Formula
New hydrolyzed whey formula
|
Other: Extensively hydrolyzed, whey protein infant formula
New hydrolyzed formula
Other Name: Baby Formula
|
|
Active Comparator: Control Formula
Commercially available hydrolyzed infant formula
|
Other: Extensively hydrolyzed, casein protein infant formula
Commercially available hydrolyzed infant formula
Other Name: Baby Formula
|
Eligibility| Ages Eligible for Study: | 2 Months to 12 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Born at term (>36 weeks gestation)
- Two (2) months to ≤ 12 years of age at enrollment
Documented Cow's Milk Allergy (CMA) within the 6 months prior to enrollment by:
- Reported convincing allergic symptoms following an exposure to milk or a milk-containing food product and [detectable serum milk-specific IgE (>0.7 kIU/L) or positive skin prick test (wheal greater than 5 mm]), OR
- Physician-supervised oral food challenge that elicited immediate allergic symptoms, OR
Results of laboratory tests highly predictive of clinical reactivity to milk
- Serum milk IgE ≥15 [kIU/L]or ≥ 5 [kIU/L if younger than 1 year OR,
- Skin prick tests mean wheal >10 mm
- Otherwise healthy
- If subject has asthma, atopic dermatitis, and/or rhinitis, must be well controlled
- Expected daily intake of at least 8 oz (240 ml) of the study formula during the open challenge phase
- Having obtained his/her legal representative's informed consent.
Exclusion Criteria:
- Children consuming mother's milk at the time of inclusion and during the trial
- Any chromosomal or major congenital anomalies
- Any major gastrointestinal disease or abnormalities other than CMA
- Chronic medical diseases (ie seizure disorders, chronic lung disease, heart problems (heart murmurs acceptable)
- Immunodeficiency
- Receiving free amino acid formula
- Anti-histamine use in 7 days prior to the first food challenge (eyedrops are acceptable)
- Oral steroid use within 14 days prior to enrollment (intranasal and topical corticosteroids are okay)
- Unstable asthma
- Severe uncontrolled eczema
- Recent ( within the last 3 months) severe anaphylactic reaction to milk
- Subject who in the Investigator's assessment cannot be expected to adhere to the study protocol
- Currently participating in another clinical trial
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01278446
Locations
| United States, Arkansas | |
| Little Rock Allergy & Asthma | |
| Little Rock, Arkansas, United States | |
| United States, California | |
| Pediatric Care Medical Group, Inc | |
| Huntington Beach, California, United States | |
| Allergy Medical Group of the North Area | |
| Roseville, California, United States, 95678 | |
| United States, Georgia | |
| Brookstone Clinical Research Center | |
| Columbus, Georgia, United States | |
| Aeroallergy Research Labs of Savannah | |
| Savannah, Georgia, United States, 31406 | |
| United States, Idaho | |
| Idaho Allergy and Asthma Specialists | |
| Eagle, Idaho, United States, 83616 | |
| United States, Indiana | |
| Deaconness Clinic | |
| Evansville, Indiana, United States | |
| United States, New Jersey | |
| Anderson & Collins Clinical Research | |
| Edison, New Jersey, United States | |
| United States, New York | |
| Mount Sinai Faculty Practice Associates Pediatric Allergy | |
| New York, New York, United States, 10029 | |
| ENT & Allergy Associates | |
| Newburgh, New York, United States | |
| United States, North Carolina | |
| Allergy Partners of Western North Carolina | |
| Asheville, North Carolina, United States, 28801 | |
| United States, Texas | |
| TTS Research | |
| Boerne, Texas, United States | |
| United States, Virginia | |
| Clinical Research Partners | |
| Henrico, Virginia, United States | |
| Advanced Pediatrics | |
| Vienna, Virginia, United States | |
Sponsors and Collaborators
Nestlé
Investigators
| Study Director: | Jose Saavedra, MD | Nestle Nutrition |
| Principal Investigator: | Anna Nowak-Wegrzyn, MD | Mount Sinai Department of Pediatrics |
More Information
No publications provided
| Responsible Party: | Nestlé |
| ClinicalTrials.gov Identifier: | NCT01278446 History of Changes |
| Other Study ID Numbers: | 09.42.PED |
| Study First Received: | January 14, 2011 |
| Last Updated: | January 16, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Nestlé:
|
Cow's Milk Allergy CMA |
Additional relevant MeSH terms:
|
Food Hypersensitivity Hypersensitivity Hypersensitivity, Immediate Immune System Diseases |
ClinicalTrials.gov processed this record on May 16, 2013